老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Arbutus Biopharma Corporation

4.11
-0.0400-0.96%
盘后：4.120.0110+0.27%19:37 EDT
成交量：348.19万
成交额：1,426.28万
市值：8.09亿
市盈率：5.21
高：4.16
开：4.13
低：4.05
收：4.15
52周最高：5.45
52周最低：3.50
股本：1.97亿
流通股本：1.51亿
量比：0.74
换手率：2.31%
股息：- -
股息率：- -
每股收益(TTM):0.7896
每股收益(LYR):-0.1748
净资产收益率：89.58%
总资产收益率：48.84%
市净率：3.13
市盈率(LYR):-23.51

数据加载中...

总览公司新闻资讯公告
2019/08/20

重要事件披露

Current report, item 5.02
2019/08/09

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/08/09

重要事件披露

Current report, items 8.01 and 9.01
2019/08/05

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/08/05

重要事件披露

Current report, items 2.02 and 9.01
2019/07/18

重要事件披露

Current report, item 8.01
2019/07/17

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/17

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/16

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/15

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/15

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/12

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/12

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/12

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/12

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
更多